- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Discovering allatostatin type-C receptor specific agonists ; volume:15 ; number:1 ; day:10 ; month:5 ; year:2024 ; pages:1-15 ; date:12.2024
Nature Communications ; 15, Heft 1 (10.5.2024), 1-15, 12.2024
- Urheber
-
Kahveci, Kübra
Düzgün, Mustafa Barbaros
Atis, Abdullah Emre
Yılmaz, Abdullah
Shahraki, Aida
Coskun, Basak
Durdagi, Serdar
Birgul Iyison, Necla
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-48156-w
- URN
-
urn:nbn:de:101:1-2407220951126.197316148815
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kahveci, Kübra
- Düzgün, Mustafa Barbaros
- Atis, Abdullah Emre
- Yılmaz, Abdullah
- Shahraki, Aida
- Coskun, Basak
- Durdagi, Serdar
- Birgul Iyison, Necla
- SpringerLink (Online service)
Ähnliche Objekte (12)
Novel Ghrelin receptor agonists and inverse agonists to alter energy homeostasis
Highly potent, selective acylguanidine type histamine H2-receptor agonists : synthesis and structure-activity relationships
Novel multi-objective affinity approach allows to identify pH-specific μ-opioid receptor agonists
Toll-like receptor and C-type lectin receptor agonists attenuate osteogenic differentiation in human dental pulp stem cells
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes
Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
Evaluation of carboxamide-type synthetic cannabinoids as CB1/CB2 receptor agonists: difference between the enantiomers
Toll-like receptor 2 agonists inhibit human fibrocyte differentiation
Effects of oxytocin receptor agonists on hair growth promotion
Detection of aryl hydrocarbon receptor agonists in human samples
Discovering highly selective and diverse PPAR-delta agonists by ligand based machine learning and structural modeling
Adipocyte-type fatty acid-binding protein as shuttle for peroxisome proliferator activated receptor γ [gamma] agonists
Novel Ghrelin receptor agonists and inverse agonists to alter energy homeostasis
Highly potent, selective acylguanidine type histamine H2-receptor agonists : synthesis and structure-activity relationships
Novel multi-objective affinity approach allows to identify pH-specific μ-opioid receptor agonists
Toll-like receptor and C-type lectin receptor agonists attenuate osteogenic differentiation in human dental pulp stem cells
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes
Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
Evaluation of carboxamide-type synthetic cannabinoids as CB1/CB2 receptor agonists: difference between the enantiomers
Toll-like receptor 2 agonists inhibit human fibrocyte differentiation
Effects of oxytocin receptor agonists on hair growth promotion
Detection of aryl hydrocarbon receptor agonists in human samples
Discovering highly selective and diverse PPAR-delta agonists by ligand based machine learning and structural modeling
Adipocyte-type fatty acid-binding protein as shuttle for peroxisome proliferator activated receptor γ [gamma] agonists
Novel Ghrelin receptor agonists and inverse agonists to alter energy homeostasis
Highly potent, selective acylguanidine type histamine H2-receptor agonists : synthesis and structure-activity relationships
Novel multi-objective affinity approach allows to identify pH-specific μ-opioid receptor agonists
Toll-like receptor and C-type lectin receptor agonists attenuate osteogenic differentiation in human dental pulp stem cells
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes
Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
Evaluation of carboxamide-type synthetic cannabinoids as CB1/CB2 receptor agonists: difference between the enantiomers
Toll-like receptor 2 agonists inhibit human fibrocyte differentiation
Effects of oxytocin receptor agonists on hair growth promotion
Detection of aryl hydrocarbon receptor agonists in human samples
Discovering highly selective and diverse PPAR-delta agonists by ligand based machine learning and structural modeling